- Home
- FOXX vs CYCN Comparison
FOXX vs CYCN Comparison
Compare FOXX & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FOXX | CYCN |
|---|---|---|
| Founded | 2017 | 2018 |
| Country | United States | United States |
| Employees | 25 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.2M | 16.6M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | FOXX | CYCN |
|---|---|---|
| Price | $2.50 | $3.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.1K | ★ 67.3K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.26 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,074,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.70 |
| 52 Week Low | $1.71 | $1.03 |
| 52 Week High | $7.90 | $8.48 |
Technical Indicators
Market Signals| Indicator | FOXX | CYCN |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 46.00 |
| Support Level | $2.26 | $3.04 |
| Resistance Level | $4.90 | $3.97 |
| Average True Range (ATR) | 0.28 | 0.42 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 12.15 | 11.60 |
Price Performance
Historical ComparisonAbout FOXX Foxx Development Holdings Inc.
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.